Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists
Authors:
- 21 March 2011
- journal article
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 8 (4) , 341-347
Abstract
The major limitation for the maturation of dendritic cells (DCs) using Toll-like receptor (TLR) agonists is their decreased ability to migrate into lymph nodes compared with conventional DCs. CD38 can be used as a multifunctional marker to modulate migration, survival and Th1 responses of DCs. CD74 has been shown to negatively regulate DC migration. The goal of this study was to investigate the combinations of TLR agonists and interferons (IFNs) that most effectively regulate CD38 and CD74 expression on DCs. Synergistic TLR agonist stimulation in combination with IFN-α and IFN-γ was the best method for regulating CD38 and CD74 expression and inducing the highest secretion of IL-12p70. An in vitro migration assay showed that DCs treated with this combination had significantly enhanced migratory ability, similar to that observed in cells expressing CD38, CD74 and CCR7. The results of this study suggest that an alternative maturation protocol in which two TLR ligands are combined with type I and II IFNs generates potent DCs that have both a high migratory capacity and high IL-12p70 production.Keywords
This publication has 25 references indexed in Scilit:
- Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccinesCancer Immunology, Immunotherapy, 2009
- Regulation of Dendritic Cell Migration by CD74, the MHC Class II-Associated Invariant ChainScience, 2008
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during MaturationCancer Research, 2008
- Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cellsHuman Immunology, 2007
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cellsNature Immunology, 2005
- α-Type-1 Polarized Dendritic CellsCancer Research, 2004
- Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cellsBiochemical Journal, 2003
- IFN‐α enhances CD40 ligand‐mediated activation of immature monocyte‐derived dendritic cellsInternational Immunology, 2002
- The Plasticity of Dendritic Cell Responses to Pathogens and Their ComponentsScience, 2001
- Human CD38: a glycoprotein in search of a functionImmunology Today, 1994